Originally published In Press as doi:10.1074/jbc.M201777200 on April 19, 2002
J. Biol. Chem., Vol. 277, Issue 27, 24427-24434, July 5, 2002
Coupling of Cell Energetics with Membrane Metabolic
Sensing
INTEGRATIVE SIGNALING THROUGH CREATINE KINASE PHOSPHOTRANSFER
DISRUPTED BY M-CK GENE KNOCK-OUT*
M. Roselle
Abraham,
Vitaliy A.
Selivanov,
Denice M.
Hodgson,
Darko
Pucar,
Leonid V.
Zingman,
Be
Wieringa
,
Petras P.
Dzeja,
Alexey E.
Alekseev, and
Andre
Terzic§
From the Division of Cardiovascular Diseases, Departments of
Medicine, Molecular Pharmacology, and Experimental Therapeutics,
Mayo Clinic, Rochester, Minnesota 55905 and the
Center
for Molecular Life Sciences, University Medical Center, University of
Nijmegen, Nijmegen 6500, The Netherlands
Received for publication, February 21, 2002, and in revised form, April 16, 2002
 |
ABSTRACT |
Transduction of metabolic signals is essential in
preserving cellular homeostasis. Yet, principles governing integration
and synchronization of membrane metabolic sensors with cell metabolism remain elusive. Here, analysis of cellular nucleotide fluxes and nucleotide-dependent gating of the ATP-sensitive
K+ (KATP) channel, a prototypic metabolic
sensor, revealed a diffusional barrier within the submembrane space,
preventing direct reception of cytosolic signals. Creatine kinase
phosphotransfer, captured by 18O-assisted 31P
NMR, coordinated tightly with ATP turnover, reflecting the cellular energetic status. The dynamics of high energy phosphoryl transfer through the creatine kinase relay permitted a high fidelity
transmission of energetic signals into the submembrane compartment
synchronizing KATP channel activity with cell metabolism.
Knock-out of the creatine kinase M-CK gene disrupted signal
delivery to KATP channels and generated a cellular
phenotype with increased electrical vulnerability. Thus, in the
compartmentalized cell environment, phosphotransfer systems shunt
diffusional barriers and secure regimented signal transduction
integrating metabolic sensors with the cellular energetic network.
 |
INTRODUCTION |
Maintenance of cellular homeostasis critically depends on the
ability of the cell to adjust diverse energy-dependent
processes in response to metabolic challenge (1-3). This requires
efficient monitoring of cellular metabolism, secure delivery of
information to energetic sensors, and accurate translation of metabolic
signals into cellular response (4-10). Advances have been made in
resolving the molecular identity and regulatory properties of energetic signal transducers (11, 12), yet mechanisms that integrate and
synchronize metabolic sensors with cell metabolism are only partially
understood (13-15).
ATP-sensitive K+ (KATP) channels are membrane
metabolic sensors, which act as alarm systems to adjust cell electrical
activity and regulate vital functions as diverse as hormone secretion, neurotransmitter release, or cytoprotection (6, 9, 11, 16-20).
KATP channels are expressed in high density in
metabolically active tissues, in particular heart muscle, where the
pore-forming Kir6.2 protein assembles with the regulatory sulfonylurea
receptor SUR2A subunit to form functional hetero-octameric complexes
(21-23). While ATP closes KATP channels by interacting
with Kir6.2, metabolic sensing seems to proceed through interactions of
ATP/ADP with nucleotide-binding domains of SUR (9, 16, 24-27). In this regard, active membrane ATPases constantly reduce the local ATP concentration setting the submembrane ATP/ADP ratio distinct from that
of the "bulk" cytosol (15, 28-31). However, such independent nucleotide fluctuations within a particular cell compartment (15, 31)
would hamper proper recognition of cellular signals rendering KATP channels ineffective metabolic sensors.
In response to metabolic alterations, the membrane content of
polyphosphoinositides has been implicated in defining the
ATP-sensitivity of cardiac KATP channels (32). Yet, altered
KATP channel sensitivity per se may not provide
an efficient mechanism of metabolic signal transduction as drastic
reduction in the channel responsiveness to ATP, induced by mutation of
Kir6.2, has no apparent consequences on channel behavior and/or
membrane electrical activity in metabolically competent cardiac cells
(33). Rather, coordination of membrane sensor function with the
cellular metabolic status mandates effective transfer of energetic
signals between intracellular compartments (2, 15). Cells with high and
fluctuating energy demands, such as cardiomyocytes, possess catalyzed
phosphotransfer circuits that facilitate energetic signaling between
sites of ATP production and utilization (3, 5). Emerging evidence
suggests that phosphotransfer networks can process metabolic
information for delivery to metabolic sensors, thereby serving a
critical role in cellular homeostasis (2, 3, 34, 35). In this way, the
phosphotransfer enzyme adenylate kinase physically associates with
KATP channel proteins to facilitate communication of
mitochondrial signals and promote channel opening in stress (34). A
related signal delivery function has been suggested for the most active phosphotransfer enzyme in the myocardium, creatine kinase, which could
control KATP channel closure and prevent accidental channel opening (3, 36, 37). Isoforms of creatine kinase are found in distinct
intracellular compartments, including membranes where KATP
channels reside (13, 38). Substrates of creatine kinase regulate
nucleotide-dependent KATP channel gating and
can overcome potassium channel opener-induced channel activation (36,
37, 39). In fact, in opener-primed cardiomyocytes inhibition of creatine kinase reduces the effect of mitochondrial uncoupling on
KATP channel activity (40). Although an intimate
relationship between phosphotransfer enzymes and the channel itself has
been suggested (3, 36, 37, 40, 41), the requirement for creatine kinase
phosphotransfer in synchronizing metabolic sensor function in response
to fluctuations in the cellular metabolic state has not been defined.
Here, we demonstrate that the dynamics of high energy phosphoryl
transfer through the creatine kinase system coordinates
KATP channel activity with cellular metabolism contributing
to an integrative mechanism for delivery of energetic signals to
the membrane sensor. Deletion of the M-CK gene, which
encodes the major creatine kinase isoform, disrupted creatine
kinase-dependent signal delivery to KATP
channels and generated a phenotype with increased electrical vulnerability.
 |
EXPERIMENTAL PROCEDURES |
Creatine Kinase Knock-out--
Mice lacking the M-creatine
kinase (M-CK)1 isoform were
derived from embryonic stem cells carrying a replacement mutation in the M-CK gene (1). Inactivation of M-CK expression was
achieved by homologous DNA recombination with a HygroB cassette vector used to replace exon 2 and parts of introns 1 and 2 in the
M-CK gene. Homozygous M-CK-knock-out mice were compared with
age-matched wild-type controls.
Channel Recording--
Cardiomyocytes, isolated from wild-type
and M-CK knock-out mice or guinea pig ventricles (34), were bathed in
(mM) KCl, 140; MgCl2, 1; EGTA, 5; HEPES-KOH, 5 (pH 7.3). Patch electrodes (7-10 M
) were filled with
(mM) KCl, 140; CaCl2, 1; MgCl2, 1; HEPES-KOH, 5 (pH 7.3). For the open cell-attached patch, bath solution
was supplemented with glucose (1 g/liter), malic acid (5 mM), and pyruvic acid (5 mM). Following seal
formation with the patch pipette, cell permeabilization was achieved by
digitonin (5-8 µg/ml) applied through a second pipette (filled with
5 µg/ml propidium iodide and 0.5 µg/ml rhodamine). Under
ultraviolet light, rhodamine served for visualization of solution flow,
and propidium iodide staining of the cell nucleus indicated formation
of the open cell-attached patch configuration (36, 37). Channel
activity was measured at
60 mV.
Phosphotransfer Scanned by NMR
Spectroscopy--
18O-assisted 31P NMR is
based on incorporation of 18O, provided from
18O-water, into cellular phosphates proportionally to the
rate of enzymatic reactions involved (42, 43).
The 18O-phosphoryl labeling procedure detects only
newly generated molecules containing 18O-labeled
phosphoryls reflecting net flux through an individual phosphotransfer
pathway. Hearts were perfused at 37 °C with 95% O2, 5%
CO2 saturated buffer (in mM: 123 NaCl, 6 KCl,
2.5 CaCl2, 0.5 EDTA, 19 NaHCO3, 1.2 MgSO4, 11 glucose, and 20 units/liter insulin). Hypoxia was
induced with 95%N2, 5% CO2 gassed buffer, to
reduce partial oxygen pressure to 20-30 mm Hg. 18O
labeling was achieved using the buffer supplemented with 40% of
18O-H2O (Isotec) for 30 s. During this
time 18O labeling is still within the initial pseudolinear
phase of the labeling kinetic curve, which reaches full saturation only
after 2 min following application of 18O-H2O.
Hearts were freeze-clamped and extracted in 600 mM
HClO4 and 1 mM EDTA. 18O-induced
shifts in 31P NMR spectra of ATP and creatine phosphate
were recorded at 242.9 MHz in a Bruker 14 T spectrometer (42, 43) and
phosphotransfer fluxes calculated as described (38).
Enzymatic Activity--
Hearts homogenized in (in
mM) 10 HEPES, 1 EGTA, 1 dithiothreitol, 1 aprotinin,
0.2 phenylmethylsulfonyl fluoride, and 1 µg/ml leupeptin (pH 7.4)
were spun at 5,000 × g. Supernatant was centrifuged at
100,000 × g and membrane pellets suspended by
sonication in (in mM) 20 HEPES (pH 7.4), 140 NaCl, 5 KCl, 2 MgCl2, 0.5 dithiothreitol, 1 aprotinin, 0.2 phenylmethylsulfonyl fluoride, and 2 µg/ml leupeptin. Creatine kinase
activity was determined with a coupled enzyme assay (38).
Action Potentials--
Mouse hearts were perfused at 90 mm Hg
with (in mM) NaCl, 108; KCl, 5; HEPES, 5; glucose or
deoxyglucose, 5; sodium acetate, 20; MgCl2, 1;
CaCl2, 2; malate, 1; pyruvate, 5; and insulin, 5 units/liter (pH 7.4, 37 °C). Monophasic action potentials were recorded from the left ventricular epicardial surface using a probe (EP
Technologies) while pacing at 130-ms cycle length and 10-ms pulse width
(Accupulser, World Precision Instruments). In guinea pig hearts,
action potentials were measured without pacing.
Allosteric Model of Channel
Gating--
Nucleotide-dependent KATP channel
gating was simulated by an allosteric model where four identical
binding sites for ATP and ADP co-exist within the octameric
stoichiometry of the KATP channel complex (16, 22). Binding
of ATP to the pore-forming Kir6.2 subunit inhibits channel opening (24,
25), whereas binding of ADP to the regulatory SUR subunit antagonizes
ATP-binding to Kir6.2 (6, 26, 44). Distribution of channel species
(Di; i = 0 to 4) with 0-4 ADP bound
molecules was as follows,
|
(Eq. 1)
|
with the percentage of Di species expressed
as a function of ADP concentration,
|
(Eq. 2)
|
where
|
(Eq. 3)
|
and kADP the dissociation constant
of ADP from SUR, independent from ATP binding. Analogously to Equations
1-3, the distribution of channel species (Ti) with
0-4 ATP bound molecules was derived as follows,
|
(Eq. 4)
|
with k0 and
k1 representing dissociation constants for ATP
binding to Kir6.2 in the absence and presence of ADP at the associated SUR (Fig. 1, A and B). The best fits of
experimental data from ATP-induced KATP channel inhibition
in the absence of ADP, at saturating ADP and at below saturating ADP
revealed, respectively, the values for k0,
k1, and kADP, with more
than one ATP required to close the channel octamer.
Computation of Diffusional Restriction between Cell
Compartments--
Diffusional restriction was estimated by integrating
membrane ATPase activities and diffusional nucleotide fluxes (Fig.
1C). Membrane ATP consumption
(JATPase) was simulated as a Michaelis-Menten reaction with the Michaelis constant at 0.05 mM (45).
Sarcolemmal ATPase activity (1,800 nmol/min/g wet weight) was
derived from total ATPase activity in working hearts measured by
18O-assisted 31P NMR (300 nmol/min/mg of
protein), assuming that 120 mg of protein (with 1 mg of sarcolemmal
protein) is contained in 1 g of tissue and that ~5% of total
energy is consumed by sarcolemmal ATPases (46). Nucleotide diffusion
(with a coefficient D) was calculated according to Fick's
law as one-dimensional flux (through total cell area in 1 g of
tissue, S) perpendicular to the membrane. Diffusional flux
for ATP was as follows,
|
(Eq. 5)
|
where JATP(x) is ATP flux at
distance x. At steady-state, with
JATP constant, C =
DS/
x
defining,
|
(Eq. 6)
|
where [ATP]b and [ATP]sub are
cytosolic bulk and subsarcolemmal ATP concentration,
respectively. Diffusional flux for ADP was described analogously as in
Equation 6. [ATP]sub and [ADP]sub, as a function of [ATP]b (Fig. 1D), were
defined from the following equation.
|
(Eq. 7)
|
 |
RESULTS |
Metabolic Sensing in the Submembrane Compartment--
The defining
property of cardiac KATP channels as membrane metabolic
sensors is their overt inhibition by ATP, which can be antagonized by
MgADP (Fig. 1A).
KATP channels adopt their highest sensitivity to ATP in the
absence of MgADP and convert to a range of lower ATP sensitivities with
increasing concentrations of MgADP (Fig. 1A). The regulatory
SUR2A subunit harbors an intrinsic ATPase activity (36, 44) that
facilitates conformational transitions imparting low or high ATP
sensitivity to the KATP channel complex (37). MgADP
prolongs the lifetime of the conformation associated with reduced
sensitivity to ATP (37). Allosteric modeling, which integrated
KATP channel stoichiometry and channel-nucleotide
interactions (Fig. 1B), demonstrated that on saturating
ADP-binding sites (at >100 µM ADP) no further reduction
in ATP sensitivity can be achieved (Fig. 1, A and
B), in accord with the efficacy of ADP to antagonize ATP-induced channel inhibition (47). For MgADP to open at least 1% of
KATP channels, required for significant action potential shortening at 6-10 mM cytosolic ATP (47-50), ATP at the
channel site needs to be reduced to <3 mM (Fig. 1,
C and D). Local drop in ATP could be generated by
membrane ATPases (30, 51), including ATP hydrolysis by the
KATP channel itself (36, 37, 44), provided that
nucleotide mobility between the cytosol and submembrane is
limited (31) (Fig. 1C). Calculations, based on
membrane ATPase activity and nucleotide gradients between the
cytosolic bulk and subsarcolemmal space, revealed a strong
diffusional hindrance with an apparent diffusion coefficient
D = 2.3·10
11
cm2/s.2 This
value, 5 orders of magnitude lower than values for nucleotide diffusion
in the cytosol (52), is in line with the restricted diffusion of
molecules previously observed in the structurally crowded submembrane
space of living cells (51, 53). Such a diffusional barrier implies
virtual confinement of the metabolic sensor within the submembrane
zone, impeding direct exposure to cytosolic signals. Thus, integration
of KATP channel activity with cell metabolism requires
efficient mechanisms able to shunt diffusional restrictions for proper
delivery of energetic signals.

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 1.
Nucleotide-dependent gating of
KATP channels. A and B, MgADP
antagonizes ATP-induced inhibition of cardiac KATP channels
(inset). In excised patches, the ATP sensitivity of
KATP channels was defined by an IC50 of 27 ± 5 µM in the absence (open triangles)
versus 270 ± 19 µM in the presence
(closed circles) of 100 µM ADP
(n = 3-9). Relative channel activity
(curves in A) constructed based on an allosteric
model of nucleotide-dependent KATP channel
gating (B) and expressed as a probability for the channel to
be in an open state (columns
T0-T1). In the absence of
ADP, channels adopt the highest sensitivity to ATP (row
D0) defined solely by the microscopic
dissociation constant k0 = 45 µM
(curve 1 in A). At saturating ADP concentrations,
KATP channels convert to channel species with the lowest
ATP sensitivity (row D4) defined solely by
k1 = 450 µM (curve 4 in
A). kADP (12.5 µM) was
determined at different concentrations of ADP (curve 1, 0;
curve 2, 10 µM ADP; curve 3, 50 µM ADP; curve 4, 100 µM ADP;
curve 5, 500 µM ADP; curve 6, 1,000 µM ADP). C, membrane ATPases and diffusional
restrictions generate nucleotide gradients between cytosol and
subsarcolemma, generating lower ATP and higher MgADP at the channel
site. D, Relationships between bulk and subsarcolemmal
adenine nucleotide levels when nucleotide diffusional fluxes are at
steady state (J = J ). Subsarcolemmal ATP
(ATPsub) and ADP (ADPsub) were calculated from
Equation 7 (see "Experimental Procedures"). At bulk ATP
(ATPb) between 4 and 10 mM, ATPsub
follows ATPb, while ADPsub remains constant due
to saturation of ATPase activity. At ATPb = 7 mM, ATPsub = 3 mM, sufficient to
activate 1% of KATP channels at saturating
ADPb (inset, curves from A expressed
as percent of open KATP channels).
|
|
Creatine Kinase Phosphotransfer Synchronized with Cellular Energy
Turnover Sets Nucleotide-dependent KATP Channel
Gating--
Creatine kinase molecules are spatially arranged between
cellular sites of ATP production and utilization, providing an
integrated network for high energy phosphoryl conduction (1, 3, 38, 54-56). Here, net phosphotransfer flux through the creatine kinase system was captured in intact heart using 18O-assisted
31P NMR and was found to be tightly synchronized with
cellular ATP turnover (Fig.
2A). Labeling of phosphoryl
oxygens in creatine phosphate, which reflects net flux through creatine
kinase, paralleled that of
-phosphate in ATP, an indicator of total
cellular high energy flux (Fig. 2A). On average, the
percentage of 18O in creatine phosphate was comparable with
that of
-ATP, i.e. 55 ± 4% (n = 5)
versus 61 ± 3% (n = 5), respectively
(Fig. 2B). Such a vigorous creatine kinase-catalyzed
phosphotransfer would rapidly dissipate local nucleotide gradients and
could therefore transmit cellular metabolic signals to membrane
metabolic sensors. In fact, creatine kinase catalysis was found high in
the cardiac membrane fraction, i.e. 6.2 ± 0.6 µmol/min/mg (n = 3), and was sensitive to the
conventional creatine kinase inhibitor 2,4-dinitrofluorobenzene (DNFB),
which reduced such activity to 0.5 ± 0.1 µmol/min/mg
(n = 3). To assess the role of creatine kinase flux in
regulating KATP channels as metabolic sensors, channel
behavior was measured in the absence and presence of creatine kinase
phosphotransfer. To maintain a relative integrity of the cellular
infrastructure, cardiomyocytes were permeabilized by local and brief
application of digitonin to the region of the cell distal from the
patched area (Fig. 2C). In such open cell-attached patch
configuration, removal of creatine phosphate inactivated creatine
kinase phosphotransfer and induced an aberrant sensitivity of
KATP channels toward ATP (Fig. 2D). Indeed, ATP
at 100 µM failed to inhibit KATP channels (Fig. 2D), a concentration that keeps channels closed in
excised membrane patches (Fig. 2E). The reduced ATP
sensitivity indicates that, despite clamped bulk nucleotide
concentrations by continuous cell perfusion, local levels of ATP are
decreased and ADP increased in an environment of active membrane
ATPases. Activation of creatine kinase phosphotranfer, by addition
of creatine phosphate, restored the KATP channel
responsiveness to ATP (Fig. 2D) presumably through scavenging ADP and dissipating the membrane ATPase-induced nucleotide gradient. Creatine phosphate had no significant effect on its own, but
secured KATP channel closure in open cell-attached patches in the presence of low ATP concentrations, which in inside-out patches
produced only partial channel inhibition (Fig. 2, E and F). In the presence of creatine kinase substrates,
inhibition of creatine kinase phosphotransfer by DNFB in permeabilized
cells uncoupled KATP channels from phosphotransfer
regulation (Fig. 2F). Coupling was restored by providing
purified creatine kinase to bypass the irreversible inhibition of
endogenous creatine kinase by DNFB (Fig. 2F). Thus, the
creatine phosphate/creatine kinase system is a determinant of the
KATP channel sensitivity to ATP. In permeabilized cells, in
the absence of creatine kinase flux (JCK = 0),
the IC50 for ATP-induced inhibition was 270 ± 2 µM (n = 4; Fig. 2E), close to
the value measured in the presence of saturating MgADP in excised
patches (Fig. 1A). Active creatine kinase flux
(JCK
0) significantly reduced the
IC50 to 7 ± 1 µM (n = 4), even below the sensitivity of the channel toward ATP seen in
excised patches (Fig. 2E). Thus, creatine kinase flux can
shunt nucleotide gradients between the bulk and subsarcolemmal space
and facilitate delivery of metabolic signals that translate into
KATP channel-dependent sensing of the cellular
energetic state.

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 2.
Creatine kinase phosphotransfer determines
nucleotide-dependent KATP channel gating.
A, spectra of 18O-labeled -ATP and CrP
captured by 18O-assisted 31P NMR. Incorporation
of 18O induces an isotope shift in the 31P
spectra of ATP and CrP. 16O,
18O1, 18O2, and
18O3 designate -ATP and CrP phosphoryls
containing 0-3 atoms of 18O. -ATP is recorded as a
doublet due to homonuclear scalar coupling between - and
-phosphates. 18O labeling of CrP and ATP are
comparable in magnitude, indicating that creatine kinase is responsible
for transfer of the majority of newly synthesized ATP. B,
average incorporation of 18O into phosphoryls of CrP
reflects creatine kinase-catalyzed phosphotransfer and was ~90% of
18O incorporation into -ATP, which measures total
cellular energy turnover (n = 5). C,
permeabilization of cardiomyocytes for open cell-attached patch
formation. i, transmitted light image of the initial step
showing a patch-pipette (box 1) attached to the proximal
edge of a cardiac cell and a perfusion pipette (box 2)
approaching the distal edge of the same cell. ii-iv,
fluorescent images showing flow of a digitonin-containing solution
(visualized with rhodamine (ii)) and staining of the nucleus
(visualized with propidium iodide (iii)) upon cell
permabilization; immediate withdrawal of the perfusion pipette
(iv) following open cell-attached patch formation secures
channel recording within a fairly intact intracellular architecture.
D, KATP channel activity, in an open
cell-attached patch, was vigorous in the absence of ATP and was
inhibited by 2 mM, but not 0.1 mM
ATPb. Yet, 0.1 mM ATPb inhibited
channel activity following application of CrP. E,
concentration-response curves defining ATP-induced KATP
channel inhibition in excised (open circles) and in open
cell-attached patches in the absence (open triangles) and
presence (closed triangles) of 1 mM CrP.
Solid curves were constructed based on the allosteric model
of channel regulation (with a recalculated k0 = 10 µM) using the highest ATP sensitivity in the presence
of CrP), in conjunction with nucleotide diffusion
(J ,
J ), ATPase
(JATPase), and creatine kinase
(JCK) fluxes. F, by itself CrP had no
significant effect on KATP channels. CrP-induced channel
inhibition, in the presence of ATP, was irreversibly antagonized by
DNFB and partially restored by purified creatine kinase
(CK). Current was recorded at 21 °C.
|
|
Creatine Kinase Phosphotransfer Dynamics Transduce Metabolic
Stress-induced Signals into KATP Channel-driven Membrane
Electrical Events--
In normoxia, when cardiac KATP
channels are closed, vigorous incorporation of 18O atoms
into creatine phosphate reflected the high creatine kinase phosphotransfer rate of the myocardium (Fig.
3A). Hypoxia markedly reduced
creatine kinase flux, from 279 ± 8 nmol CrP/min/mg of protein
(n = 3) to 64 ± 17 nmol CrP/min/mg of protein
(n = 3; p < 0.05), indicating a
~75% decrease in creatine kinase phosphotransfer (Fig.
3A). This reduction in creatine kinase phosphotransfer
reflects a 4-fold drop, from 36 ± 1 to 9 ± 2 nmol/mg of
protein, in creatine phosphate levels following hypoxia. Thus, under
hypoxic stress, creatine kinase has a reduced ability to equilibrate
nucleotide levels between the cytosol and subsarcolemma. Estimated
subsarcolemmal concentrations of ATP ([ATP]sub) and ADP
([ADP]sub) were deduced by integrating diffusional
restriction (C), bulk concentrations ([ATP]b,
[ADP]b), and membrane ATPase activity
(JATPase; see Equation 7) with creatine kinase
flux (JCK).

View larger version (49K):
[in this window]
[in a new window]
|
Fig. 3.
Creatine kinase phosphotransfer dynamics
translate cellular energetic status into membrane electrical
events. A, hypoxia reduces creatine kinase
(CK) phosphotransfer rate measured by 31P NMR in
18O-labeled hearts. B and C,
simulation of nucleotide-dependent KATP channel
gating, based on the allosteric model of channel regulation integrated
with nucleotide diffusional fluxes and membrane ATPase activity
(JATPase), in the presence of vigorous creatine
kinase flux (JATPase = JCK) in normoxia (B)
versus reduced (by 75%) creatine kinase flux
(JATPase JCK) in
hypoxia (C). While in normoxia [ATP]b = [ATP]sub ([ADP]sub = 10 µM),
in hypoxia ATPsub<ATPb ([ADP]sub = 3 mM). Solid curves depict ATP-induced
KATP channel inhibition at defined ATPsub and
ADPsub. D, percent of open KATP
channels at different creatine kinase (CK) flux (180, 300, 450, and 900 nmol/min/g wet weight), expressed relative to
creatine kinase flux in normoxia (JCK = JATPase = 1,800 nmol/min/g wet weight).
Each curve was constructed based on the allosteric model of channel
gating, integrated with the model for nucleotide diffusion and ATPase
activity (Equation 7 under "Experimental Procedures"), at different
creatine kinase flux. E, shortening of action potential
duration (APD), in hypoxia recorded by the monophasic action potential
electrode. APD was corrected to heart rate using the modified Bazett's
formula: APD = APD90/T1/2,
where APD is corrected APD;
APD90, APD measured at 90% repolarization; and
T, cardiac cycle length.
|
|
|
(Eq. 8)
|
In normoxia, with creatine kinase flux compensating for membrane
ATPase activity (JATPase = JCK), nucleotide gradients were dissipated with
[ATP]b = [ATP]sub and [ADP]b = [ADP]sub (Fig. 3B). With equilibrated
[ATP]b and [ATP]sub, at 6-10
mM, KATP channels remained closed as the
concentration-response curve for ATP-induced channel inhibition is far
below the actual intracellular ATP levels (Fig 3B). In
hypoxia, reduced creatine kinase flux (JATPase
JCK) unmasked the membrane ATPase-induced
drop in ATP ([ATP]b > [ATP]sub) and
increase in ADP ([ADP]b < [ADP]sub) in the
subsarcolemmal space (Fig. 3C). In this way, metabolic
challenge resulting in altered creatine kinase phosphotransfer could
bring subsarcolemmal nucleotide levels to a range that now lies in the
steeper portion defining ATP-dependent channel gating,
securing effective signal delivery to KATP channels (Fig.
3C). A drop of 75% in creatine kinase phosphotransfer
(JCK:4), observed in hypoxia (Fig.
3A) at cytosolic ATP <6 mM, would translate
into activation of >1% of KATP channels sufficient for
significant action potential shortening in a cardiac cell (50), as
computed from the allosteric model of nucleotide-dependent
channel gating (Fig. 1B), taking into account nucleotide
diffusion, membrane ATPase, and creatine kinase fluxes (Fig.
3D). Indeed, cardiac action potential duration was significantly decreased from 230 ± 4 ms prior to 130 ± 7 ms
following hypoxic stress (Fig. 3E). Thus, the dynamics of
creatine kinase phosphotransfer, governed by the cellular metabolic
condition, determine the percentage of open KATP channels
and provide a mediator translating cellular energetic signals into
membrane electrical events.
Knock-out of Creatine Kinase Disrupts Signal Delivery to the
Metabolic Sensor--
Cytosolic creatine kinase (M-CK) is the major
creatine kinase isoform in the heart (1). Deletion of the
M-CK gene blunted creatine kinase phosphotransfer and
essentially eliminated creatine kinase activity in the sarcolemma (Fig.
4A). In wild-type
cardiomyocytes, KATP channel activity was highly sensitive
to creatine kinase-mediated channel inhibition, revealed from titration
with creatine phosphate (IC50 = 94 ± 5 µM, n = 5; Fig. 4, B and
C). This indicates tight integration of creatine
kinase-catalyzed energetic signaling with KATP channel
activity. In contrast, in cells lacking M-CK, KATP channels
were uncoupled from the cellular energetic infrastructure and were no
longer sensitive to creatine phosphate regulation (Fig. 4,
B-D). Thus, cells lacking the creatine kinase
phosphotransfer system display a defective regulation of
nucleotide-gated membrane functions.

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 4.
Knock-out of M-CK disrupts
creatine kinase-dependent control of KATP
channel gating. A, spectrophotometric recordings of
creatine kinase (CK) activity in sarcolemmal fraction from
wild-type (WT) and creatine kinase knock-out (M-CK
KO) hearts. Creatine kinase activity was diminished from 2.9 ± 0.2 (n = 3) in wild type to 0.1 ± 0.02 (n = 3) µmol/min/mg of protein in M-CK knock-out.
B, concentration-response curves for CrP-induced
KATP channel inhibition, at 100 µM ATP, in
open cell-attached patches from WT and M-CK knock-out cells. Channel
activity expressed relative to that measured in the absence of CrP.
C and D, KATP channel recordings in
WT (C) and M-CK knock-out (D). While in WT CrP
enhanced KATP channel inhibition by 100 µM
ATP, in the M-CK knock-out the creatine kinase substrate was virtually
deprived of any significant effect. Temperature was 31 °C.
|
|
Fidelity in Membrane Metabolic Sensing Lost with Deletion of the
M-CK Gene--
Besides creatine kinase, additional phosphotransfer
pathways, such as the glycolytic system, have been identified as
interrelated components of the cellular energetic network (2, 3, 5). Here, in wild-type cardiomyocytes, inhibition of phosphoryl delivery through the glycolytic system by deoxyglucose did not elicit a KATP channel response (Fig.
5A), suggesting privileged
control of this metabolic sensor by creatine kinase. In contrast, in
cells lacking M-CK, metabolic stress induced with deoxyglucose
triggered KATP channel opening (Fig. 5, B and
C). In fact, aberrant coupling of KATP channels
with cellular metabolism in creatine kinase knock-out hearts generated
a phenotype with electrical instability manifested by premature
shortening of action potentials in response to deoxyglucose (Fig. 5,
D and E). The rate of stress-induced action
potential shortening was significantly faster in creatine kinase
knock-out (0.042 ± 0.005 min
1, n = 4) than wild-type (0.016 ± 0.004 min
1,
n = 4) hearts (p < 0.05; Fig.
5D). Accordingly, action potential duration, measured at
90% of repolarization, was essentially unchanged (94 ± 4% of
control value, n = 4) in wild type, but was reduced, by
39 ± 9% (n = 4), in the M-CK knock-out following
a 7-min long application of deoxyglucose (Fig. 5E). Thus,
creatine kinase phosphotransfer is required for proper linkage of
cellular energetics with membrane excitability.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 5.
Electrical instability under stress in M-CK
knock-out hearts. A, prolonged (>20 min) metabolic
challenge induced by deoxyglucose (DOG), an inhibitor of glycolysis,
did not trigger electrical events in WT cardiomyocytes, which remain
sensitive to an uncoupler of mitochondrial oxidative phosphorylation,
dinitrophenol (DNP). B, M-CK knock-out
(M-CK KO) hearts are highly susceptible to DOG, which
triggers early opening of KATP channels. C, time
course of DOG effect in WT (n = 3; open
squares) and M-CK knock-out (n = 3; closed
circles). While in WT there was no effect over the 17-min-long DOG
application, in M-CK knock-out the time course of DOG-induced
KATP channel opening was characterized by a half-maximal
activation time of 16.1 ± 0.3 min (slope: 0.8 ± 0.1 min)
obtained by the best fit of experimental data with Boltzman's
function. In A-C, channel recording was in the open
cell-attached mode at 31 °C. D, rates of action potential
shortening in WT (closed circles) and M-CK knock-out
(open squares) hearts, measured throughout DOG application
fitted by linear regressions (solid lines). E,
action potential in WT (left) and M-CK knock-out
(right) hearts prior to (solid line) and
following a 7-min long application of 5 mM DOG
(dashed line).
|
|
 |
DISCUSSION |
Metabolic signal transduction governs vital functions that enable
cells to respond to metabolic challenges, but how the operation of
metabolic sensors is orchestrated to accurately sense the cellular energetic status has remained a long-standing enigma. Using cardiac KATP channels as prototypic membrane metabolic sensors, we
demonstrate that phosphotransfer enzyme-catalyzed metabolic signal
delivery synchronizes channel gating with cell energetics. Genetic
disruption of the creatine kinase pathway generated a phenotype with
increased electrical vulnerability, underscoring the significance of an intact intracellular phosphotransfer network in integrating metabolic signaling.
The extremely low diffusional flux of nucleotides, estimated here in
the subsarcolemmal space, indicates that KATP channels are
virtually secluded from cellular bulk nucleotide oscillations. Restricted metabolite mobility in the premembrane area could be due to
molecular crowding and reduction in the free diffusional space as
previously suggested for different cellular compartments (13-15, 53).
In fact due to the "fuzzy space" in the submembrane (31), channel
gating would be relegated to local fluctuations of nucleotides
("metabolic background noise"), independent of the cellular
metabolic status. Instead of random fluctuations in adenine
nucleotides, which would distort energetic signaling, we provide direct
evidence that the creatine kinase phosphotransfer system controls
exchange of nucleotides securing signal processing between the
subsarcolemmal space and cytosolic compartment.
Indeed, the dynamics of creatine kinase flux closely followed total ATP
turnover, indicating tight coupling between creatine kinase
phosphotransfer and the cellular metabolic state (38, 43). Present
throughout the cell, creatine kinase reactions form a phosphotransfer
relay able to respond to changes in the cellular metabolic state and
propagate metabolic waves between cellular compartments (3, 57, 58).
Such catalyzed phosphotransfer can deliver metabolic signals at a rate
exceeding simple diffusion (38, 58). Accordingly, here, under the
normal status of cell metabolism, vigorous creatine kinase
phosphotransfer dissipated local nucleotide gradients created by
membrane ATPases and diffusional restrictions in the channel
environment, keeping KATP channels predominantly closed.
Under metabolic stress, however, reduced creatine kinase
phosphotransfer unmasked nucleotide changes in the channel vicinity
alerting KATP channels to adjust membrane excitability.
Reduced creatine kinase flux under metabolic insult is known to be
associated with concomitant up-regulation of adenylate kinase
phosphotransfer, which catalyzes the conversion of ATP to ADP at the
channel site (34, 57). Such interplay between phosphotransfer pathways
effectively amplifies the metabolic signal translating into
KATP channel opening and ultimately shortening of the
cardiac action potential under stress (19, 59). Thus, membrane
metabolic sensors respond to the dynamics of cellular phosphotransfer
flux, reflecting with high fidelity the energetic status of a cell.
Integration of phosphotransfer with KATP channels appears
critical in supporting metabolic signaling. Knock-out of the dominant creatine kinase isoform, M-CK, disrupted KATP channel
regulation by creatine phosphate. This produced a cellular phenotype
characterized by increased electrical instability, in line with
observations that muscles lacking creatine kinase genes display
abnormal contractile response and reduced energetic efficiency (1, 4,
54, 55). Moreover, coupling of creatine kinase with
Ca2+-ATPases of the sarcoplasmic reticulum, which is
essential in securing Ca2+ handling and proper kinetics of
intracellular Ca2+ signals, is compromised following
deletion of creatine kinase genes (60). In this regard, creatine kinase
can also functionally couple with KATP channels through
direct creatine kinase-dependent regulation of the ATPase
catalytic cycle harbored within SUR, the channel regulatory subunit
(36, 37). The ATP hydrolysis cycle at SUR drives conformational
transitions associated with distinct outcomes on channel behavior, with
creatine kinase promoting disengagement of the MgADP-bound state and
KATP channel closure (37). Thus, nucleotide exchange
between cellular phosphotransfer catalyzed by creatine kinase and
membrane ATPases, including the channel's own ATPase, provides a
mechanistic basis for coupling cell energetics with metabolic signal transduction.
Along with creatine kinase, distinct phosphotransfer systems can also
efficiently communicate energetic signals to metabolic signal
transducers and regulate ATP-sensitive cellular components (3, 34, 61).
The interrelationship between intracellular energetic pathways is
revealed upon deletion of the M-CK gene, which translated
into redistribution of metabolic flux through glycolytic enzymes (56,
62). In accord with the adaptive potential of phosphotransfer pathways
(1, 5, 42), such energetic remodeling was sufficient to maintain
apparently normal KATP channel gating in the absence of
metabolic challenge in the M-CK knock-out heart. However, knock-out of
M-CK did produce increased electrical vulnerability manifested by
premature action potential shortening in hearts stressed by inhibition
of glycolytic enzymes. Thus, an intact phosphotransfer network is a
prerequisite for optimal decoding of energetic signals securing
adequate function of a metabolic sensor. The significance of these
findings is underscored in human disease where compromised creatine
kinase phosphotransfer has been associated with cardiac electrical
instability (63) and extrapyramidal movement disorders (64).
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grants HL-64822 and HL-07111 and by the American Heart Association, the
Guidant Foundation, the Marriott Foundation, the Miami Heart Research
Institute, the Bruce and Ruth Rappaport Program in Vascular Biology and
Gene Delivery, the American Physicians Fellowship for Medicine in
Israel, and the CR Program at the Mayo Clinic.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Established Investigator of the American Heart Association. To whom
correspondence should be addressed: Division of Cardiovascular Diseases, Depts. of Medicine, Molecular Pharmacology, and Experimental Therapeutics, Mayo Clinic, Guggenheim 7, 200 First St. SW, Rochester, MN 55905. Tel.: 507-284-2747; Fax: 507-284-9111; E-mail:
terzic.andre@mayo.edu.
Published, JBC Papers in Press, April 19, 2002, DOI 10.1074/jbc.M201777200
2
D = C·
x/S was derived from C = 0.45 cm3/min/g wet weight (Equation 7, Fig.
1D), assuming a subsarcolemmal space width (
x) of 10
5 cm and a total surface of cells in 1 g of
tissue (1012 µm3) S = 3,200 cm2/g wet weight for an average cardiac cell
(10 × 20 × 100 µm) with a volume of 20,000 µm3 and a surface of 6,400 µm2.
 |
ABBREVIATIONS |
The abbreviations used are:
M-CK, M-creatine kinase;
DNFB, 2,4-dinitrofluorobenzene;
CrP, creatine
phosphate;
WT, wild-type;
DOG, deoxyglucose.
 |
REFERENCES |
| 1.
|
van Deursen, J.,
Heerschap, A.,
Oerlemans, F.,
Ruitenbeek, W.,
Jap, P.,
ter Laak, H.,
and Wieringa, B.
(1993)
Cell
74,
621-631[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
O'Rourke, B.,
Ramza, B. M.,
and Marban, E.
(1994)
Science
265,
962-966[Abstract/Free Full Text]
|
| 3.
|
Dzeja, P. P.,
and Terzic, A.
(1998)
FASEB J.
12,
523-529[Abstract/Free Full Text]
|
| 4.
|
Steeghs, K.,
Benders, A.,
Oerlemans, F.,
de Haan, A.,
Heerschap, A.,
Ruitenbeek, W.,
Jost, C.,
van Deursen, J.,
Perryman, B.,
Pette, D.,
Bruckwilder, M.,
Koudijs, J.,
Jap, P.,
Veerkamp, J.,
and Wieringa, B.
(1997)
Cell
89,
93-103[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Janssen, E.,
Dzeja, P. P.,
Oerlemans, F.,
Simonetti, A. W.,
Heerschap, A.,
de Haan, A.,
Rush, P. S.,
Terjung, R. R.,
Wieringa, B.,
and Terzic, A.
(2000)
EMBO J.
19,
6371-6381[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Nichols, C. G.,
Shyng, S. L.,
Nestorowicz, A.,
Glaser, B.,
Clement, J. P.,
Gonzalez, G.,
Aguilar-Bryan, L.,
Permutt, M. A.,
and Bryan, J.
(1996)
Science
272,
1785-1787[Abstract]
|
| 7.
|
Abraham, M. R.,
Jahangir, A.,
Alekseev, A. E.,
and Terzic, A.
(1999)
FASEB J.
13,
1901-1910[Abstract/Free Full Text]
|
| 8.
|
Koster, J. C.,
Marshall, B. A.,
Ensor, N.,
Corbett, J. A.,
and Nichols, C. G.
(2000)
Cell
100,
645-654[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Aguilar-Bryan, L.,
Bryan, J.,
and Nakazaki, M.
(2001)
Recent Prog. Horm. Res.
56,
47-68[Abstract]
|
| 10.
|
Mahajan, V. B.,
Pai, K. S.,
and Cunningham, D. D.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
12062-12067[Abstract/Free Full Text]
|
| 11.
|
Inagaki, N.,
Gonoi, T.,
Clement, J. P.,
Namba, N.,
Inazawa, J.,
Gonzalez, G.,
Aguilar-Bryan, L.,
Seino, S.,
and Bryan, J.
(1995)
Science
270,
1166-1170[Abstract/Free Full Text]
|
| 12.
|
Hardie, D. G.,
Carling, D.,
and Carlson, M.
(1998)
Annu. Rev. Biochem.
67,
821-855[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Kaasik, A.,
Veksler, V.,
Boehm, E.,
Novotova, M.,
Minajeva, A.,
and Ventura-Clapier, R.
(2001)
Circ. Res.
89,
153-159[Abstract/Free Full Text]
|
| 14.
|
Saks, V. A.,
Kaambre, T.,
Sikk, P.,
Eimre, M.,
Orlova, E.,
Paju, K.,
Piirsoo, A.,
Appaix, F.,
Kay, L.,
Regitz-Zagrosek, V.,
Fleck, E.,
and Seppet, E.
(2001)
Biochem. J.
356,
643-657[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Weiss, J. N.,
and Korge, P.
(2001)
Circ. Res.
89,
108-110[Free Full Text]
|
| 16.
|
Ashcroft, F. M.,
and Gribble, F. M.
(1998)
Trends Neurosci.
21,
288-294[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Seino, S.
(1999)
Annu. Rev. Physiol.
61,
337-362[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Miki, T.,
Liss, B.,
Minami, K.,
Shiuchi, T.,
Saraya, A.,
Kashima, Y.,
Horiuchi, M.,
Ashcroft, F.,
Minokoshi, Y.,
Roeper, J.,
and Seino, S.
(2001)
Nat. Neurosci.
4,
507-512[Medline]
[Order article via Infotrieve]
|
| 19.
|
Yamada, K., Ji, J. J.,
Yuan, H.,
Miki, T.,
Sato, S.,
Horimoto, N.,
Shimizu, T.,
Seino, S.,
and Inagaki, N.
(2001)
Science
292,
1543-1546[Abstract/Free Full Text]
|
| 20.
|
Jovanovic, A.,
Jovanovic, S.,
Lorenz, E.,
and Terzic, A.
(1998)
Circulation
98,
1548-1555[Abstract/Free Full Text]
|
| 21.
|
Inagaki, N.,
Gonoi, T.,
Clement, J. P.,
Wang, C. Z.,
Aguilar-Bryan, L.,
Bryan, J.,
and Seino, S.
(1996)
Neuron
16,
1011-1017[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Clement, J. P.,
Kunjilwar, K.,
Gonzalez, G.,
Schwanstecher, M.,
Panten, U.,
Aguilar-Bryan, L.,
and Bryan, J.
(1997)
Neuron
18,
827-838[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Lorenz, E.,
and Terzic, A.
(1999)
J. Mol. Cell. Cardiol.
31,
425-434[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Tucker, S. J.,
Gribble, F. M.,
Zhao, C.,
Trapp, S.,
and Ashcroft, F. M.
(1997)
Nature
387,
179-183[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Drain, P., Li, L.,
and Wang, J.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
13953-13958[Abstract/Free Full Text]
|
| 26.
|
Shyng, S. L.,
Ferrigni, T.,
and Nichols, C. G.
(1997)
J. Gen. Physiol.
110,
643-654[Abstract/Free Full Text]
|
| 27.
|
Zingman, L. V.,
Hodgson, D. M.,
Bienengraeber, M.,
Karger, A. B.,
Kathmann, E. C.,
Alekseev, A. E.,
and Terzic, A.
(2002)
J. Biol. Chem.
277,
14206-14210[Abstract/Free Full Text]
|
| 28.
|
Weiss, J. N.,
and Lamp, S. T.
(1988)
Science
238,
67-69
|
| 29.
|
Lederer, W. J.,
and Nichols, C. G.
(1989)
J. Physiol. (Lond.)
419,
193-211[Abstract/Free Full Text]
|
| 30.
|
Weiss, J. N.,
and Venkatesh, N.
(1993)
Cardiovasc. Drugs Ther.
7,
499-505[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Lederer, W. J.,
Niggli, E.,
and Hadley, R. W.
(1990)
Science
248,
283[Free Full Text]
|
| 32.
|
Shyng, S. L.,
and Nichols, C. G.
(1998)
Science
282,
1138-1141[Abstract/Free Full Text]
|
| 33.
|
Koster, J. C.,
Knopp, A.,
Flagg, T. P.,
Markova, K. P.,
Sha, Q.,
Enkvetchakul, D.,
Betsuyaku, T.,
Yamada, K. A.,
and Nichols, C. G.
(2001)
Circ. Res.
89,
1022-1029[Abstract/Free Full Text]
|
| 34.
|
Carassco, A. J.,
Dzeja, P. P.,
Alekseev, A. E.,
Pucar, D.,
Zingman, L. V.,
Abraham, M. R.,
Hodgson, D.,
Bienengraeber, M.,
Puceat, M.,
Janssen, E.,
Wieringa, B.,
and Terzic, A.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
7623-7628[Abstract/Free Full Text]
|
| 35.
|
Elvir-Mairena, J. R.,
Jovanovic, A.,
Gomez, L. A.,
Alekseev, A. E.,
and Terzic, A.
(1996)
J. Biol. Chem.
271,
31903-31908[Abstract/Free Full Text]
|
| 36.
|
Bienengraeber, M.,
Alekseev, A. E.,
Abraham, M. R.,
Carrasco, A. J.,
Moreau, C.,
Vivaudou, M.,
Dzeja, P. P.,
and Terzic, A.
(2000)
FASEB J.
14,
1943-1952[Abstract/Free Full Text]
|
| 37.
|
Zingman, L. V.,
Alekseev, A. E.,
Bienengraeber, M.,
Hodgson, D.,
Karger, A. B.,
Dzeja, P. P.,
and Terzic, A.
(2001)
Neuron
31,
233-245[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Dzeja, P. P.,
Vitkevicius, K. T.,
Redfield, M. M.,
Burnett, J. C.,
and Terzic, A.
(1999)
Circ. Res.
84,
1137-1143[Abstract/Free Full Text]
|
| 39.
|
Nichols, C. G.,
and Lederer, W. J.
(1990)
J. Physiol. (Lond.)
423,
91-110[Abstract/Free Full Text]
|
| 40.
|
Sasaki, N.,
Sato, T.,
Marban, E.,
and O'Rourke, B.
(2001)
Am. J. Physiol.
280,
H1882-H1888
|
| 41.
|
Crawford, R. M.,
Ranki, H. J.,
Botting, C. H.,
Budas, G. R.,
and Jovanovic, A.
(2002)
FASEB J.
16,
102-104[Abstract/Free Full Text]
|
| 42.
|
Pucar, D.,
Janssen, E.,
Dzeja, P. P.,
Juranic, N.,
Macura, S.,
Wieringa, B.,
and Terzic, A.
(2000)
J. Biol. Chem.
275,
41424-41429[Abstract/Free Full Text]
|
| 43.
|
Pucar, D.,
Dzeja, P. P.,
Bast, P.,
Juranic, N.,
Macura, S.,
and Terzic, A.
(2001)
J. Biol. Chem.
276,
44812-44819[Abstract/Free Full Text]
|
| 44.
|
Matsuo, M.,
Tanabe, K.,
Kioka, N.,
Amachi, T.,
and Ueda, K.
(2000)
J. Biol. Chem.
275,
28757-28763[Abstract/Free Full Text]
|
| 45.
|
Chazov, E. I.,
Smirnov, V. N.,
Saks, V. A.,
Rosenshtraukh, L. V.,
Lipina, N. V.,
and Levitsky, D. O.
(1980)
Adv. Myocardiol.
1,
139-153[Medline]
[Order article via Infotrieve]
|
| 46.
|
Golhaber, J. I.
(1997)
in
The Myocardium
(Langer, G. A., ed)
, pp. 325-383, Academic Press, San Diego, CA
|
| 47.
|
Weiss, J. N.,
Venkatesh, N.,
and Lamp, S. T.
(1992)
J. Physiol. (Lond.)
447,
649-673[Abstract/Free Full Text]
|
| 48.
|
Bittl, J. A.,
DeLayre, J.,
and Ingwall, J. S.
(1987)
Biochemistry
26,
6083-6090[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Decking, U. K.,
Reffelmann, T.,
Schrader, J.,
and Kammermeier, H.
(1995)
Am. J. Physiol.
269,
H734-H742[Medline]
[Order article via Infotrieve]
|
| 50.
|
Nichols, C. G.,
and Lederer, W. J.
(1991)
Am. J. Physiol.
261,
H1675-H1686 |